Literature DB >> 8152520

Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies.

J D Steketee1.   

Abstract

Cocaine produces a motor-stimulant response in part by its actions within the mesolimbic dopamine system. Repeated exposure to cocaine induces an augmented motor activity response which is termed behavioral sensitization, or reverse tolerance. Previous studies have suggested that sensitization may result from increased dopamine neuronal activity in the A10 region; the origin of the mesolimbic dopamine system. However, the exact mechanisms involved in the development of behavioral sensitization remain to be elucidated. Studies on other forms of sensitization in the nervous system suggest a critical role for increased protein kinase C (PKC) activity in the development of the sensitized response. As a first step in examining the role of PKC in cocaine-induced behavioral sensitization, the effect of intra-A10 administration of a PKC inhibitor, H7, on the acute motor-stimulant response to cocaine was studied. Intra-A10 injections of H7 dose-dependently (1.0-30.0 nmol/side) inhibited cocaine (15.0 mg/kg)-induced motor activity. Pretreatment with H7 (30.0 nmol/side) also blocked the cocaine-induced rise of extracellular dopamine in a terminal region of the mesolimbic dopamine system, the nucleus accumbens, as measured by in vivo microdialysis. These data suggest that activation of protein kinases may be important in cocaine-induced motor activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8152520     DOI: 10.1016/0028-3908(93)90023-v

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

Review 1.  Protein kinase C isozymes and addiction.

Authors:  M Foster Olive; Robert O Messing
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

Review 2.  A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?

Authors:  Erika Abrial; Guillaume Lucas; Hélène Scarna; Nasser Haddjeri; Laura Lambás-Señas
Journal:  Mol Neurobiol       Date:  2011-10-05       Impact factor: 5.590

3.  Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?

Authors:  Marcela Pereira; Roberto Andreatini; Rainer K W Schwarting; Juan C Brenes
Journal:  Psychopharmacology (Berl)       Date:  2014-01-11       Impact factor: 4.530

Review 4.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

5.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

6.  Reversing Cocaine-Induced Plasticity with Zeta Inhibitory Peptide.

Authors:  Andre U Deutschmann; Jeffrey D Lenz; Anna G McGrath; Lisa A Briand
Journal:  J Neurosci       Date:  2019-08-13       Impact factor: 6.167

7.  Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

Authors:  R Maldonado; O Valverde; C Garbay; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

8.  Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity.

Authors:  Alexander G Zestos; Colleen Carpenter; Youngsoo Kim; Malcolm J Low; Robert T Kennedy; Margaret E Gnegy
Journal:  ACS Chem Neurosci       Date:  2018-11-08       Impact factor: 4.418

Review 9.  Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.